When Should Medicare Mandate Participation In Alternative Payment Models?

Alternative payment models Bundled Payments for Care Improvement Bundled charges Care Coordination Cost savings Costs and spending Fee-for-service Health care providers Health policy Markets Medicaid services Medicare Patient engagement Payment Payment models Quality of care Value

Journal

Health affairs (Project Hope)
ISSN: 1544-5208
Titre abrégé: Health Aff (Millwood)
Pays: United States
ID NLM: 8303128

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 4 2 2020
pubmed: 6 2 2020
medline: 15 5 2021
Statut: ppublish

Résumé

The Centers for Medicare and Medicaid Services continues to propose and implement alternative payment models (APMs) to shift Medicare payment away from fee-for-service and toward approaches that emphasize health care value. As APMs expand in scope, one critical question is whether they should engage providers on a voluntary or a mandatory basis. Clinicians and policy makers may view the benefits and drawbacks of these two modes of participation differently. In this Analysis we compare the benefits and drawbacks of mandatory and voluntary participation, based on clinical versus policy perspectives, and we argue that both modes are necessary for APMs to achieve the goal of improving value. Policy makers should match the mode of participation and related financial incentives to each clinical scenario in which an APM is implemented. We propose ways to coordinate mandatory and voluntary APMs based on clinical scenarios.

Identifiants

pubmed: 32011936
doi: 10.1377/hlthaff.2019.00570
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-309

Auteurs

Joshua M Liao (JM)

Joshua M. Liao is medical director of payment strategy, director of the Value and Systems Science Lab, and an assistant professor in the Department of Medicine, University of Washington, in Seattle, and an adjunct senior fellow at the Leonard Davis Institute of Health Economics, University of Pennsylvania, in Philadelphia.

Mark V Pauly (MV)

Mark V. Pauly is the Bendheim Professor in the Health Care Management Department at the Wharton School, University of Pennsylvania.

Amol S Navathe (AS)

Amol S. Navathe ( amol. navathe@gmail. com ) is a core investigator at the Corporal Michael J. Cresencz Veterans Affairs Medical Center, in Philadelphia; an assistant professor in the Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania; and codirector of the Healthcare Transformation Institute, associate director of the Center for Health Incentives and Behavioral Economics, and senior fellow at the Leonard Davis Institute of Health Economics, University of Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH